2017 Q3 Form 10-Q Financial Statement
#000114420417042457 Filed on August 11, 2017
Income Statement
Concept | 2017 Q3 | 2017 Q2 | 2016 Q2 |
---|---|---|---|
Revenue | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Cost Of Revenue | |||
YoY Change | |||
Gross Profit | |||
YoY Change | |||
Gross Profit Margin | |||
Selling, General & Admin | $850.0K | $1.300M | $220.0K |
YoY Change | 325.0% | 490.91% | |
% of Gross Profit | |||
Research & Development | $2.000M | $447.0K | $421.0K |
YoY Change | 992.9% | 6.18% | |
% of Gross Profit | |||
Depreciation & Amortization | |||
YoY Change | |||
% of Gross Profit | |||
Operating Expenses | $2.848M | $1.744M | $638.0K |
YoY Change | 643.6% | 173.35% | |
Operating Profit | -$2.848M | -$1.744M | -$638.0K |
YoY Change | 643.6% | 173.35% | |
Interest Expense | $106.0K | $93.00K | $87.00K |
YoY Change | 19.1% | 6.9% | |
% of Operating Profit | |||
Other Income/Expense, Net | -$100.0K | -$662.0K | -$133.0K |
YoY Change | -37.89% | 397.74% | |
Pretax Income | -$2.950M | -$2.410M | -$770.0K |
YoY Change | 446.3% | 212.99% | |
Income Tax | |||
% Of Pretax Income | |||
Net Earnings | -$2.948M | -$2.406M | -$771.0K |
YoY Change | 441.91% | 212.06% | |
Net Earnings / Revenue | |||
Basic Earnings Per Share | |||
Diluted Earnings Per Share | -$295.9K | -$289.0K | -$92.33K |
COMMON SHARES | |||
Basic Shares Outstanding | 10.04M shares | ||
Diluted Shares Outstanding |
Balance Sheet
Concept | 2017 Q3 | 2017 Q2 | 2016 Q2 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $26.05M | $34.68M | |
YoY Change | 86733.33% | ||
Cash & Equivalents | $16.05M | $34.68M | |
Short-Term Investments | $10.00M | ||
Other Short-Term Assets | $130.0K | $20.00K | |
YoY Change | 333.33% | ||
Inventory | |||
Prepaid Expenses | $126.0K | $22.00K | |
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $26.18M | $34.71M | |
YoY Change | 43533.33% | ||
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | |||
YoY Change | |||
Other Assets | |||
YoY Change | |||
Total Long-Term Assets | -$4.000K | -$5.000K | |
YoY Change | |||
TOTAL ASSETS | |||
Total Short-Term Assets | $26.18M | $34.71M | |
Total Long-Term Assets | -$4.000K | -$5.000K | |
Total Assets | $26.18M | $34.71M | |
YoY Change | 43526.67% | ||
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $1.910M | $830.0K | |
YoY Change | 377.5% | ||
Accrued Expenses | $80.00K | $340.0K | |
YoY Change | -94.2% | ||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | |
YoY Change | |||
Long-Term Debt Due | $0.00 | $5.990M | |
YoY Change | -100.0% | ||
Total Short-Term Liabilities | $1.990M | $7.155M | |
YoY Change | -58.19% | ||
LONG-TERM LIABILITIES | |||
Long-Term Debt | $0.00 | $390.0K | |
YoY Change | -100.0% | ||
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $0.00 | $390.0K | |
YoY Change | -100.0% | ||
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $1.990M | $7.155M | |
Total Long-Term Liabilities | $0.00 | $390.0K | |
Total Liabilities | $1.990M | $7.549M | |
YoY Change | -73.64% | ||
SHAREHOLDERS EQUITY | |||
Retained Earnings | -$14.42M | -$11.47M | |
YoY Change | |||
Common Stock | $38.60M | $38.63M | |
YoY Change | |||
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $24.19M | $27.16M | |
YoY Change | |||
Total Liabilities & Shareholders Equity | $26.18M | $34.71M | |
YoY Change | 43526.67% |
Cashflow Statement
Concept | 2017 Q3 | 2017 Q2 | 2016 Q2 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | -$2.948M | -$2.406M | -$771.0K |
YoY Change | 441.91% | 212.06% | |
Depreciation, Depletion And Amortization | |||
YoY Change | |||
Cash From Operating Activities | -$1.870M | -$630.0K | -$240.0K |
YoY Change | 325.0% | 162.5% | |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$10.00M | ||
YoY Change | |||
Cash From Investing Activities | -$10.00M | ||
YoY Change | |||
FINANCING ACTIVITIES | |||
Cash Dividend Paid | |||
YoY Change | |||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | -6.750M | 35.30M | 250.0K |
YoY Change | -1600.0% | 14020.0% | |
NET CHANGE | |||
Cash From Operating Activities | -1.870M | -630.0K | -240.0K |
Cash From Investing Activities | -10.00M | ||
Cash From Financing Activities | -6.750M | 35.30M | 250.0K |
Net Change In Cash | -18.62M | 34.67M | 10.00K |
YoY Change | -186300.0% | 346600.0% | |
FREE CASH FLOW | |||
Cash From Operating Activities | -$1.870M | -$630.0K | -$240.0K |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2017Q2 | us-gaap |
Assets
Assets
|
34705000 | USD |
CY2016Q4 | us-gaap |
Assets
Assets
|
197000 | USD |
CY2017Q2 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
826000 | USD |
CY2016Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
|
506000 | USD |
CY2017Q2 | atxi |
Accruedexpensesrelatedpartycurrent
Accruedexpensesrelatedpartycurrent
|
167000 | USD |
dei |
Document Type
DocumentType
|
10-Q | ||
dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001644963 | ||
CY2017Q2 | us-gaap |
Cash
Cash
|
34683000 | USD |
CY2016Q4 | us-gaap |
Cash
Cash
|
197000 | USD |
CY2015Q4 | us-gaap |
Debt Instrument Decrease Forgiveness
DebtInstrumentDecreaseForgiveness
|
3000000 | USD |
dei |
Trading Symbol
TradingSymbol
|
ATXI | ||
dei |
Document Period End Date
DocumentPeriodEndDate
|
2017-06-30 | ||
dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q2 | ||
dei |
Entity Registrant Name
EntityRegistrantName
|
AVENUE THERAPEUTICS, INC. | ||
CY2017Q3 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
10041008 | shares |
dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | ||
dei |
Amendment Flag
AmendmentFlag
|
false | ||
dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2017 | ||
dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | ||
CY2017Q2 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
56000 | USD |
CY2016Q4 | us-gaap |
Interest Payable Current
InterestPayableCurrent
|
57000 | USD |
CY2017Q2 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
3486000 | USD |
CY2016Q4 | us-gaap |
Notes Payable Related Parties Classified Current
NotesPayableRelatedPartiesClassifiedCurrent
|
2848000 | USD |
CY2017Q2 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
2500000 | USD |
CY2016Q4 | us-gaap |
Other Notes Payable Current
OtherNotesPayableCurrent
|
1000000 | USD |
CY2017Q2 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
0 | USD |
CY2016Q4 | us-gaap |
Derivative Liabilities
DerivativeLiabilities
|
314000 | USD |
CY2017Q2 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
7155000 | USD |
CY2016Q4 | us-gaap |
Liabilities Current
LiabilitiesCurrent
|
6419000 | USD |
CY2017Q2 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
0 | USD |
CY2016Q4 | us-gaap |
Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
|
200000 | USD |
CY2017Q2 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
394000 | USD |
CY2016Q4 | us-gaap |
Long Term Notes Payable
LongTermNotesPayable
|
1826000 | USD |
CY2017Q2 | us-gaap |
Liabilities
Liabilities
|
7549000 | USD |
CY2016Q4 | us-gaap |
Liabilities
Liabilities
|
8445000 | USD |
CY2017Q2 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | USD |
CY2016Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
1000 | USD |
CY2017Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
447000 | USD |
CY2016Q4 | atxi |
Accruedexpensesrelatedpartycurrent
Accruedexpensesrelatedpartycurrent
|
1348000 | USD |
CY2017Q2 | atxi |
Accruedinterestrelatedpartycurrent
Accruedinterestrelatedpartycurrent
|
120000 | USD |
CY2016Q4 | atxi |
Accruedinterestrelatedpartycurrent
Accruedinterestrelatedpartycurrent
|
346000 | USD |
CY2017Q2 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
38625000 | USD |
CY2016Q2 | us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
421000 | USD |
CY2017Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1297000 | USD |
CY2016Q2 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
217000 | USD |
CY2017Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1744000 | USD |
CY2016Q2 | us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-638000 | USD |
CY2017Q2 | us-gaap |
Interest Expense
InterestExpense
|
93000 | USD |
CY2016Q2 | us-gaap |
Interest Expense
InterestExpense
|
87000 | USD |
CY2017Q2 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
20000 | USD |
CY2016Q2 | us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
46000 | USD |
CY2017Q2 | atxi |
Fair Value Adjustments Of Convertible Notes Payable
FairValueAdjustmentsOfConvertibleNotesPayable
|
95000 | USD |
CY2016Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
0 | USD |
CY2017Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-2406000 | USD |
CY2016Q2 | us-gaap |
Net Income Loss
NetIncomeLoss
|
-771000 | USD |
CY2017Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.70 | |
CY2016Q2 | us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.28 | |
CY2017Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
3459942 | shares |
CY2016Q2 | us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
2785865 | shares |
us-gaap |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
|
24000 | USD | |
us-gaap |
Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
|
948000 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-3067000 | USD | |
us-gaap |
Net Income Loss
NetIncomeLoss
|
-1818000 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
24000 | USD | |
us-gaap |
Share Based Compensation
ShareBasedCompensation
|
18000 | USD | |
atxi |
Fair Value Adjustments Of Convertible Notes Payable
FairValueAdjustmentsOfConvertibleNotesPayable
|
99000 | USD | |
atxi |
Fair Value Adjustments Of Convertible Notes Payable
FairValueAdjustmentsOfConvertibleNotesPayable
|
0 | USD | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
451000 | USD | |
us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
89000 | USD | |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
68000 | USD | |
us-gaap |
Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
|
60000 | USD | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
320000 | USD | |
us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
69000 | USD | |
us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
451000 | USD | |
us-gaap |
Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
|
396000 | USD | |
us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
-1000 | USD | |
us-gaap |
Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
|
0 | USD | |
atxi |
Accrued Interest Related Party
AccruedInterestRelatedParty
|
74000 | USD | |
atxi |
Accrued Interest Related Party
AccruedInterestRelatedParty
|
71000 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-655000 | USD | |
us-gaap |
Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
-1116000 | USD | |
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
638000 | USD | |
us-gaap |
Proceeds From Notes Payable
ProceedsFromNotesPayable
|
1134000 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
35141000 | USD | |
us-gaap |
Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
|
1134000 | USD | |
us-gaap |
Cash Period Increase Decrease
CashPeriodIncreaseDecrease
|
34486000 | USD | |
us-gaap |
Cash Period Increase Decrease
CashPeriodIncreaseDecrease
|
18000 | USD | |
CY2015Q4 | us-gaap |
Cash
Cash
|
14000 | USD |
CY2016Q2 | us-gaap |
Cash
Cash
|
32000 | USD |
us-gaap |
Interest Paid
InterestPaid
|
125000 | USD | |
us-gaap |
Interest Paid
InterestPaid
|
120000 | USD | |
CY2016Q3 | us-gaap |
Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
|
83333 | shares |
CY2016Q3 | us-gaap |
Preferred Stock Dividend Rate Percentage
PreferredStockDividendRatePercentage
|
0.025 | pure |
CY2016 | us-gaap |
Research And Development In Process
ResearchAndDevelopmentInProcess
|
49000 | USD |
CY2016Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
105000 | USD |
CY2017Q2 | us-gaap |
Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
|
454000 | USD |
CY2017Q2 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-11470000 | USD |
CY2016Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
-8403000 | USD |
CY2017Q2 | us-gaap |
Stockholders Equity
StockholdersEquity
|
27156000 | USD |
CY2016Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
-8248000 | USD |
CY2017Q2 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
34705000 | USD |
CY2016Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
197000 | USD |
CY2017Q2 | atxi |
Common Stock Value Issuable
CommonStockValueIssuable
|
0 | USD |
CY2016Q4 | atxi |
Common Stock Value Issuable
CommonStockValueIssuable
|
49000 | USD |
CY2016Q2 | atxi |
Fair Value Adjustments Of Convertible Notes Payable
FairValueAdjustmentsOfConvertibleNotesPayable
|
0 | USD |
CY2017Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
100000 | USD |
CY2016Q2 | us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
70000 | USD |
CY2017Q2 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2000000 | shares |
CY2017Q2 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
50000000 | shares |
CY2017Q2 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q2 | us-gaap |
Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
|
0 | USD |
CY2016Q4 | us-gaap |
Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
|
314000 | USD |
CY2017Q2 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2016Q4 | us-gaap |
Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
|
0.0001 | |
CY2016Q4 | us-gaap |
Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
|
2000000 | shares |
CY2016Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.0001 | |
CY2017Q2 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
10041008 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
3257936 | shares |
CY2017Q2 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
10041008 | shares |
CY2016Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
3257936 | shares |
CY2017Q2 | atxi |
Common Stock Shares Issuable
CommonStockSharesIssuable
|
0 | shares |
CY2016Q4 | atxi |
Common Stock Shares Issuable
CommonStockSharesIssuable
|
83532 | shares |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
580000 | USD | |
us-gaap |
Research And Development Expense
ResearchAndDevelopmentExpense
|
985000 | USD | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
1668000 | USD | |
us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
493000 | USD | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-2248000 | USD | |
us-gaap |
Operating Income Loss
OperatingIncomeLoss
|
-1478000 | USD | |
us-gaap |
Interest Expense
InterestExpense
|
188000 | USD | |
us-gaap |
Interest Expense
InterestExpense
|
172000 | USD | |
us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
81000 | USD | |
us-gaap |
Interest Expense Related Party
InterestExpenseRelatedParty
|
79000 | USD | |
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.95 | ||
us-gaap |
Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
|
0.66 | ||
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
3242602 | shares | |
us-gaap |
Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
|
2761367 | shares | |
us-gaap |
Use Of Estimates
UseOfEstimates
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> </div> <b><i><font style="FONT-SIZE: 10pt"><b><i><font style="FONT-SIZE: 10pt"><b><i><font style="FONT-SIZE: 10pt"><b><i><font style="FONT-SIZE: 10pt"><b><i><font style="FONT-SIZE: 10pt"><b><i><font style="FONT-SIZE: 10pt"><b><i><font style="FONT-SIZE: 10pt"></font></i></b></font></i></b></font></i></b></font></i></b></font></i></b></font></i></b></font></i></b> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt" align="justify"><b><i><b><i><font style="FONT-SIZE: 10pt"><strong> <i>Use of Estimates</i></strong></font></i></b></i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 29.7pt; MARGIN: 0in 0in 0pt" align="justify"><b><font style="FONT-SIZE: 10pt"> <strong><i> </i></strong></font></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-SIZE: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | ||
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
948000 | USD | |
us-gaap |
Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
|
0 | USD | |
us-gaap |
Derivatives Reporting Of Derivative Activity
DerivativesReportingOfDerivativeActivity
|
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 14.3pt; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0in 0in 0pt"> <b><i><font style="FONT-SIZE: 10pt">Valuation of Warrant Related to NSC Note</font></i></b></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 14.3pt; MARGIN: 0in 0in 0pt"> <font style="FONT-SIZE: 10pt"> </font></div> <font style="FONT-SIZE: 10pt"><font style="FONT-SIZE: 10pt"><font style="FONT-SIZE: 10pt"></font></font></font> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 13.2pt; MARGIN: 0in 0in 0pt" align="justify">In accordance with Accounting Standards Codification (“ASC”) 815 <i>Derivatives and Hedging</i>, the Company classified the fair value of the warrant (“Contingently Issuable Warrants”) that it may be obligated to issue to National Securities, Inc. (“NSC”), in connection with the transfer on October 31, 2015 of $<font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">3.0</font> million of indebtedness to NSC, as a derivative liability as there was a potential that the Company would not have a sufficient number of authorized common shares available to settle this instrument. The Company valued these Contingently Issuable Warrants using a Black-Scholes model and used estimates for an expected dividend yield, a risk-free interest rate, and expected volatility together with management’s estimate of the probability of issuance of the Contingently Issuable Warrants. At each reporting period, as long as the Contingently Issuable Warrants were potentially issuable and there was a potential for an insufficient number of authorized shares available to settle the Contingently Issuable Warrants, the Contingently Issuable Warrants should be revalued and any difference from the previous valuation date would be recognized as a change in fair value in the Company’s statement of operations. On June 26, 2017, the warrants were issued (See Note 6). </div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table> | ||
CY2017Q2 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
22000 | USD |
CY2016Q4 | us-gaap |
Prepaid Expense Current
PrepaidExpenseCurrent
|
0 | USD |
atxi |
Stock Issued During Period Conversion Of Msa Fees Into Common Value
StockIssuedDuringPeriodConversionOfMsaFeesIntoCommonValue
|
1000000 | USD | |
us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
34503000 | USD | |
atxi |
Stock Issued During Period Issuance Of Warrants Under Nsc Note
StockIssuedDuringPeriodIssuanceOfWarrantsUnderNscNote
|
750000 | USD | |
us-gaap |
Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
|
200000 | USD | |
us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
0 | USD | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
22000 | USD | |
us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
1000 | USD | |
CY2017Q2 | us-gaap |
Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
|
3.0-to-1.0 reverse stock split | |
us-gaap |
Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
|
3447000 | USD | |
us-gaap |
Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
|
0 | USD | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
37950000 | USD | |
us-gaap |
Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
|
0 | USD | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
200000 | USD | |
us-gaap |
Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
|
200000 | USD | |
us-gaap |
Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
|
1000000 | USD | |
atxi |
Warrants Issued
WarrantsIssued
|
750000 | USD | |
atxi |
Warrants Issued
WarrantsIssued
|
0 | USD | |
atxi |
Extinguishment Of Fortress Compensation Accrual
ExtinguishmentOfFortressCompensationAccrual
|
632000 | USD | |
atxi |
Extinguishment Of Fortress Compensation Accrual
ExtinguishmentOfFortressCompensationAccrual
|
0 | USD | |
atxi |
Interest On Fortress Note On Modification
InterestOnFortressNoteOnModification
|
300000 | USD | |
atxi |
Interest On Fortress Note On Modification
InterestOnFortressNoteOnModification
|
0 | USD | |
us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
200000 | USD | |
us-gaap |
Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
|
0 | USD | |
atxi |
Change Fair Value Of Convertible Note Warrents
ChangeFairValueOfConvertibleNoteWarrents
|
15000 | USD | |
atxi |
Change Fair Value Of Convertible Note Warrents
ChangeFairValueOfConvertibleNoteWarrents
|
0 | USD | |
atxi |
Agreement Description Terms
AgreementDescriptionTerms
|
(i) issue annually to Fortress, on the anniversary date of the Founders Agreement, shares of common stock equal to two and one half percent (2.5%) of the fully-diluted outstanding equity of Avenue at the time of issuance; (ii) pay an equity fee in shares of Avenue common stock, payable within five (5) business days of the closing of any equity or debt financing for Avenue or any of its respective subsidiaries that occurs after the effective date of the Founders Agreement and ending on the date when Fortress no longer has majority voting control in Avenues voting equity, equal to two and one half percent (2.5%) of the gross amount of any such equity or debt financing; and (iii) pay a cash fee equal to four and one half percent (4.5%) of Avenues annual net sales, payable on an annual basis, within ninety (90) days of the end of each calendar year. In the event of a change in control (as it is defined in the Founders Agreement), Fortress will be paid a one-time change in control fee equal to five (5x) times the product of (i) net sales for the twelve (12) months immediately preceding the change in control and (ii) four and one-half percent (4.5%). | ||
us-gaap |
Interest Expense Debt
InterestExpenseDebt
|
300000 | USD | |
atxi |
Change In Fair Value Of Convertible Notes Warrants
ChangeInFairValueOfConvertibleNotesWarrants
|
15000 | USD | |
atxi |
Modification To Interest On Fortress Note
ModificationToInterestOnFortressNote
|
300000 | USD | |
atxi |
Change In Fair Value Of Convertible Notes Payable
ChangeInFairValueOfConvertibleNotesPayable
|
99000 | USD | |
us-gaap |
Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
|
632000 | USD | |
CY2017Q2 | us-gaap |
Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
|
1.0 | USD |
CY2017Q2 | us-gaap |
Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
|
166666 | shares |
CY2017Q2 | us-gaap |
Share Price
SharePrice
|
6.00 |